Over the past 12 months, 5 insiders at ICU MEDICAL INC/DE filed 7 open-market SEC Form 4 transactions on ICUI: 4 purchases worth $2.6M and 3 sales worth $754K. Insiders have been mixed over this period. The most recent filing was on Nov 25, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 25, 25 | Daniel WoolsonVP, GM-Infusion Capital | SELL | 2.9K | $152.35 | $441K |
| Nov 11, 25 | Elisha W FinneyDirector | SELL | 1.3K | $140.42 | $180K |
| Nov 11, 25 | Virginia Ruth SanzoneVP, General Counsel | SELL | 930 | $142.35 | $132K |
| Aug 27, 25 | David C. GreenbergDirector | BUY | 602 | $126.69 | $76K |
| Aug 14, 25 | Vivek JainChairman and CEO | BUY | 19.6K | $112.92 | $2.2M |
| May 30, 25 | Virginia Ruth SanzoneVP, General Counsel | SELL | 700 | $133.62 | $94K |
| May 28, 25 | Christian B. VoigtlanderChief Operating Officer | SELL | 5.0K | $128.50 | $641K |
| May 27, 25 | Christian B. VoigtlanderChief Operating Officer | SELL | 4.9K | $131.00 | $648K |
| May 23, 25 | Christian B. VoigtlanderChief Operating Officer | SELL | 5.0K | $130.00 | $645K |
| May 22, 25 | Christian B. VoigtlanderChief Operating Officer | SELL | 5.0K | $130.03 | $645K |
| May 21, 25 | Christian B. VoigtlanderChief Operating Officer | SELL | 4.9K | $133.00 | $654K |
| May 20, 25 | Christian B. VoigtlanderChief Operating Officer | SELL | 4.9K | $137.11 | $668K |
| May 19, 25 | Elisha W FinneyDirector | SELL | 600 | $138.92 | $83K |
| May 19, 25 | Christian B. VoigtlanderChief Operating Officer | SELL | 5.6K | $138.00 | $767K |
| May 16, 25 | Christian B. VoigtlanderChief Operating Officer | SELL | 5.6K | $140.00 | $778K |
| May 15, 25 | Ben SousaChief Information Officer | SELL | 2.0K | $137.36 | $275K |
| May 15, 25 | Christian B. VoigtlanderChief Operating Officer | SELL | 5.6K | $135.55 | $753K |
| May 14, 25 | Christian B. VoigtlanderChief Operating Officer | SELL | 5.6K | $138.65 | $770K |
| May 13, 25 | David C. GreenbergDirector | SELL | 1.9K | $143.66 | $279K |
| Jan 2, 25 | Vivek JainChairman and CEO | SELL | 1.4K | $155.48 | $213K |
| Dec 6, 24 | Daniel WoolsonVP, GM-Infusion Capital | SELL | 2.2K | $156.25 | $350K |
| Dec 2, 24 | Vivek JainChairman and CEO | SELL | 8.3K | $163.96 | $1.3M |
| Nov 27, 24 | David C. GreenbergDirector | SELL | 972 | $158.11 | $154K |
| Nov 27, 24 | Christian B. VoigtlanderChief Operating Officer | SELL | 1.4K | $158.00 | $226K |
| Nov 26, 24 | Christian B. VoigtlanderChief Operating Officer | SELL | 7.5K | $160.09 | $1.2M |
| Nov 25, 24 | Christian B. VoigtlanderChief Operating Officer | SELL | 2.0K | $169.08 | $332K |
| Nov 1, 24 | Vivek JainChairman and CEO | SELL | 4.2K | $173.60 | $722K |
| Oct 1, 24 | Vivek JainChairman and CEO | SELL | 4.2K | $180.48 | $738K |
| Sep 3, 24 | Vivek JainChairman and CEO | SELL | 4.4K | $164.07 | $726K |
| Aug 30, 24 | Daniel WoolsonVP, GM-Infusion Capital | SELL | 2.5K | $163.22 | $408K |
| Aug 16, 24 | Vivek JainChairman and CEO | SELL | 12.0K | $156.04 | $1.9M |
| Aug 8, 24 | Virginia Ruth SanzoneVP, General Counsel | SELL | 2.0K | $144.11 | $295K |
| May 30, 24 | Christian B. VoigtlanderChief Operating Officer | SELL | 10.5K | $104.49 | $1.1M |
| May 16, 24 | Elisha W FinneyDirector | SELL | 300 | $104.95 | $31K |
| May 10, 24 | Ben SousaChief Information Officer | SELL | 2.0K | $105.55 | $211K |
| Mar 15, 24 | Daniel WoolsonVP, GM-Infusion Capital | SELL | 791 | $98.27 | $78K |
| Mar 14, 24 | George A LopezDirector | SELL | 8.0K | $101.87 | $813K |
| Mar 12, 24 | George A LopezDirector | SELL | 1.5K | $101.51 | $154K |
| Mar 11, 24 | George A LopezDirector | SELL | 1.9K | $104.22 | $197K |
| Mar 8, 24 | Virginia Ruth SanzoneVP, General Counsel | SELL | 3.3K | $104.57 | $345K |
| Mar 8, 24 | George A LopezDirector | SELL | 15.4K | $105.94 | $1.6M |
| Mar 7, 24 | George A LopezDirector | SELL | 19.0K | $105.77 | $2.0M |
| Mar 4, 24 | George A LopezDirector | SELL | 7.1K | $106.79 | $753K |
| Mar 4, 24 | Christian B. VoigtlanderChief Operating Officer | SELL | 6.9K | $108.30 | $735K |
| Feb 29, 24 | Smiths Group PlcOther | SELL | 830.0K | $106.08 | $88.0M |
| Feb 29, 24 | Smiths Group International Holdings LtdOther | SELL | 830.0K | $106.08 | $88.0M |
| Dec 1, 23 | Daniel WoolsonVP, GM-Infusion Capital | SELL | 1.7K | $88.03 | $152K |
| Sep 8, 23 | Christian B. VoigtlanderChief Operating Officer | SELL | 6.2K | $129.64 | $795K |
| Jul 12, 23 | Vivek JainChairman and CEO | SELL | 30.0K | $180.02 | $5.4M |
| Jun 14, 23 | Vivek JainChairman and CEO | SELL | 8.2K | $194.73 | $1.5M |
Over the past 12 months, insiders at ICU MEDICAL INC/DE filed 4 open-market purchases worth $2.6M and 3 sales worth $754K on ICUI, which makes them mixed over the period. The most recent Form 4 was filed on Nov 25, 25.
The largest recent open-market ICUI insider purchase in our data was $2.2M by Vivek Jain, Chairman and CEO, filed on Aug 14, 25.
5 different insiders at ICU MEDICAL INC/DE filed open-market SEC Form 4 transactions on ICUI over the last 12 months.
InsiderTape plots every ICUI insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every ICU MEDICAL INC/DE insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →